Patents by Inventor Al Lin

Al Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of increasing endogenous erythropoietin (EPO)
    Publication number: 20060183695
    Abstract: The present invention relates to methods for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo. Methods for treating, pretreating or preconditioning, or preventing erythropoietin-associated conditions are also included. Compounds for use in these methods are provided, as are methods of identifying such compounds.
    Type: Application
    Filed: April 17, 2006
    Publication date: August 17, 2006
    Applicant: FibroGen, Inc.
    Inventors: Stephen Klaus, Al Lin, Thomas Neff, Qingjian Wang, Volkmar Guenzler-Pukall, Michael Arend, Lee Flippin, Alex Melekhov
  • Methods of increasing endogenous erythropoietin (EPO)
    Publication number: 20060178316
    Abstract: The present invention relates to methods for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo. Methods for treating, pretreating or preconditioning, or preventing erythropoietin-associated conditions are also included. Compounds for use in these methods are provided, as are methods of identifying such compounds.
    Type: Application
    Filed: April 17, 2006
    Publication date: August 10, 2006
    Applicant: FibroGen, Inc.
    Inventors: Stephen Klaus, Al Lin, Thomas Neff, Qingjian Wang, Volkmar Guenzler-Pukall, Michael Arend, Lee Flippin, Alex Melekhov
  • Methods of increasing endogenous erythropoietin (EPO)
    Publication number: 20060178317
    Abstract: The present invention relates to methods for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo. Methods for treating, pretreating or preconditioning, or preventing erythropoietin-associated conditions are also included. Compounds for use in these methods are provided, as are methods of identifying such compounds.
    Type: Application
    Filed: April 17, 2006
    Publication date: August 10, 2006
    Applicant: FibroGen, Inc.
    Inventors: Stephen Klaus, Al Lin, Thomas Neff, Qingjian Wang, Volkmar Guenzler-Pukall, Michael Arend, Lee Flippin, Alex Melekhov
  • Condom
    Patent number: D707810
    Type: Grant
    Filed: June 27, 2012
    Date of Patent: June 24, 2014
    Assignee: Ansell Limited
    Inventors: KC Nguyen, Beng Sim Chuah, Adeline Al Lin Kung, Matthew Steven Groskorth, Chayaporn Pongthanomsak